Acadian Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $120M | Sell |
|
|||||
|
2025
Q2 | $108M | Sell |
|
|||||
|
2025
Q1 | $154M | Buy |
|
|||||
|
2024
Q4 | $44.6M | Sell |
|
|||||
|
2024
Q3 | $166M | Buy |
|
|||||
|
2024
Q2 | $65.8M | Sell |
|
|||||
|
2024
Q1 | $95.1M | Buy |
|
|||||
|
2023
Q4 | $29.4M | Sell |
|
|||||
|
2023
Q3 | $48.7M | Sell |
|
|||||
|
2023
Q2 | $150M | Sell |
|
|||||
|
2023
Q1 | $176M | Sell |
|
|||||
|
2022
Q4 | $230M | Buy |
|
|||||
|
2022
Q3 | $192M | Sell |
|
|||||
|
2022
Q2 | $467M | Buy |
|
|||||
|
2022
Q1 | $148M | Buy |
|
|||||
|
2021
Q4 | $78.8M | Buy |
|
|||||
|
2021
Q3 | $11.7M | Buy |
|
|||||
|
2021
Q2 | $8.07M | Sell |
|
|||||
|
2021
Q1 | $57.9M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $310K | Sell |
|
|||||
|
2017
Q4 | $1.58M | Buy |
|
|||||
|
2017
Q3 | $669K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $26K | Hold |
|
|||||
|
2016
Q3 | $29K | Sell |
|
|||||
|
2016
Q2 | $61K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $106K | Buy |
|
|||||
|
2014
Q2 | $119K | Buy |
|